CD276 and pachyonychia congenita: In light of this, we evaluated the antitumour activity of DS-7300a, an anti-B7-H3 ADC with a TOP1 inhibitor (DXd) payload, and demonstrated B7-H3 dependent antitumour activity in human advanced PC models in vitro and in vivo.